Reviparin sodium

Reviparin sodium (clivarine) is a second generation LMWH, developed with the aim of maximising the antithrombotic action while… Expand

BACKGROUND Oral anticoagulants and low-molecular-weight heparin are both recommended for venous thromboembolism prophylaxis after… Expand

PURPOSE Deep venous thrombosis (DVT) is a common, important complication of major orthopaedic surgery, particularly knee… Expand

Previous studies in rats show that unfractionated heparin and the low molecular weight heparin logiparin have a dose-dependent… Expand

UNLABELLED Reviparin (reviparin sodium) is a low molecular weight heparin (LMWH) that catalyses the inactivation of factors Xa… Expand

BACKGROUND Low-molecular-weight heparin is known to be safe and effective for the initial treatment of patients with proximal… Expand

A prospective, randomised, controlled clinical trial was carried out in order to elucidate the incidence of venous… Expand

Summary. A prospective, randomised, controlled clinical trial was carried out in order to elucidate the incidence of venous… Expand

Resuhs. Using the intention to treat analysis for all patients. 102 (33.3%) in tbe reviparin group and 98 (32%) in the control… Expand

Use of low molecular weight heparins (LMWHs) is now generally accepted as an ideal method of prophylaxis against postoperative… Expand